Latest Isofol Medical News & Updates

See the latest news and media coverage for Isofol. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Isofol Medical (Isofol)

Clinical-stage biotechnology company developing folate-based cancer therapies

isofolmedical.com
Headquarters
Gothenburg, Sweden
Founded year
2008
Company type
Public company
Number of employees
2–15

Last updated

Latest news about Isofol Medical (Isofol)

In short: Isofol Medical advanced its arfolitixorin clinical trials, secured key patent approvals, and strengthened its financial position through new funding.

Company announcements

Isofol

Isofol optimizes phase Ib/II study after BfArM approval

BfArM approves broader inclusion criteria, direct comparison with leucovorin and addition of study centers for faster recruitment.

Unlock all announcements with a

Media coverage

Morningstar

Isofol Medical AB 5IU

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive...

Barron's

Isofol Medical AB

Isofol Medical AB is a biotech company, which engages in the development of the cancer drug Arfolitixorin, intended primarily for the treatment of colorectal cancer...

FinanzNachrichten

Isofol Medical AB: Isofol receives top guarantee commitment and letters of intent corresponding to 42 percent of upcoming warrant exercise

GOTHENBURG, Sweden, 11 March 2026 - Isofol Medical AB ("Isofol" or the "Company") announces today that the Company has received a top guarantee commitment from...

Unlock all articles with a

Never miss news about Isofol

Track Isofol and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.